Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on July 9, 2025
Mobility City Delivers Fast, Reliable Mobility Equipment Repairs to Veterans Nationwide
EIN Presswire
·
July 9, 2025
Driven by Urgency | Trusted for Quality Repairs | Helping Veterans Improve their Quality of Life BOCA RATON, FL, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- Mobility City, the leading network providing repair service for mobility and accessibility …
Dallas Spine Surgeon Michael Wheeler, MD, Elevates Precision with Advanced Spinal Navigation and Custom Templating
EIN Presswire
·
July 9, 2025
DALLAS, TX, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- Michael Wheeler, MD, a leading orthopedic spine surgeon in Dallas, is transforming the spine surgery landscape through advanced spinal navigation and individualized spine templating. These …
United States Digital PCR Market Size, Share & Report 2033
EIN Presswire
·
July 9, 2025
United States digital PCR market reached USD 1.3 Billion in 2024 and will grow at a CAGR of 21.09% and is expected to reach USD 7.2 Billion by 2033. BROOKLYN, NY, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- Market Overview 2025-2033 United …
United States Dietary Supplements Market Size, Share, Trends, Industry Analysis, Report 2025-2033
EIN Presswire
·
July 9, 2025
The United States dietary supplements market is growing due to health awareness, fitness trends, and demand for preventive healthcare products. BROOKLYN, NY, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- Market Overview 2025-2033 The United …
Primus Software Corporation Launches PrimeOne: A NextGen Platform for Business Process Discovery & Scalable Automation
EIN Presswire
·
July 9, 2025
PrimeOne equips leaders with a unified view of process performance and automation ROI - advancing strategic decision-making and enterprise -wide efficiencies. ATLANTA, GA, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- Primus Software Corporation …
Gozellix Receives Permanent HCPCS Code
GlobeNewswire
·
July 9, 2025
MELBOURNE, Australia and INDIANAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that its next-generation PSMA1 PET2 imaging agent, Gozellix® (kit for the preparation of gallium-68 ( …
Retirement Tax Consultants Launches a Comprehensive Roth Analysis to Help Avoid the 7 Hidden Costs of Traditional IRAs
EIN Presswire
·
July 9, 2025
Get an In-Depth Roth Analysis at a 30% Discount Through July 2025 MCKINNEY, TX, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- For individuals evaluating whether to convert their traditional IRAs, 401(k)s, or other tax-qualified retirement plans to a …
End-to-End Automated Threat Detection and Response in HYCU Air-Gapped and Immutable Backup and DR Solution
EIN Presswire
·
July 9, 2025
StoneFly announces the addition of advanced Threat Detection and Response capabilities built into the StoneFly DR365H HYCU Backup and DR Appliance. CASTRO VALLEY, CA, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- StoneFly, Inc. (iscsi.com), a …
One Big Beautiful Bill Act Tightens ACA Access—HCSMs Offer a Simple, Values-Based Alternative
EIN Presswire
·
July 9, 2025
With new ACA restrictions taking effect, many Americans are re-evaluating their healthcare options. HCSMs offer a values-based, cost-sharing alternative. AUSTIN, TX, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- With the recent passage of H.R.1 - …
Isotopes Market: Roadmap to Innovation and Emerging Segments 2025–2033
EIN Presswire
·
July 9, 2025
The global isotopes market is witnessing notable growth, driven by increasing demand across medical and industrial applications. WILMINGTON, DE, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- The global isotopes market is witnessing notable growth, …
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
July 9, 2025
BOSTON, July 09, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today announced …
Helvetic Clinics: 20 % vækst bekræfter lederskab i tandturisme
EIN Presswire
·
July 9, 2025
Helvetic Clinics Budapest bekræfter europæisk markedslederskab inden for tandturisme med 20 % vækst i første halvdel af 2025 BUDAPEST, BUDAPEST, HUNGARY, July 9, 2025 /EINPresswire.com/ -- Helvetic Clinics, der af adskillige eksperter er anerkendt som …
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
GlobeNewswire
·
July 9, 2025
RADNOR, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2025 after the market close on Wednesday, …
Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance
GlobeNewswire
·
July 9, 2025
Jason Campagna, MD, PhD, joins Inventiva as President of R…
Inventiva annonce la nomination de Jason Campagna en tant que Président de la R&D et Directeur Médical et de Martine Zimmermann en tant que Vice-Présidente Exécutive en charge des affaires réglementaires et de l’assurance qualité
GlobeNewswire
·
July 9, 2025
Jason Campagna, MD, PhD, rejoint Inventiva en tant que Président de la R…
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 9, 2025
SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis
GlobeNewswire
·
July 9, 2025
NOVATO, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 ( …
Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine
GlobeNewswire
·
July 9, 2025
The previously disclosed and now published RESILIENT data show that once-nightly TNX-102 SL achieved statistically significant improvement in the primary endpoint of reducing fibromyalgia pain versus placebo, and was generally well tolerated These results …
Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
July 9, 2025
Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and Waldenström macroglobulinemia (WM) Secured $15M license …
VIIGROUP and 360Medlink Complete Merger to Deliver AI Powered Digital Medicine Solutions
EIN Presswire
·
July 9, 2025
Transforming Life Sciences with AI Driven, Clinically Validated Digital Medicine Solutions for Patients, Payors and Providers BETHLEHEM, PA, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- VIIGROUP Inc., a leader in generative AI healthcare innovation …